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Introduction
Ovarian carcinoma is the most fatal of the neoplasms
that affect the female reproductive organs. Patients
usually seek medical advice when cancer clinical
advancement precludes complete recovery. Even
though the subsequent stages of molecular mecha-
nisms of carcinogenesis have been discovered, the eti-
ology and pathology of ovarian carcinoma are still not
fully elucidated.  According to the type of carcinogenic
cells, ovarian carcinomas can be divided mainly into:
surface epithelial-stromal, sex cord-stromal, germ cell
mucous tumors [1]. Endometrioid cancer is the third
most common of the epithelial ovarian neoplasms [2],
accounting for approximately 10% of cases [3]. This
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Abstract: Endometrioid carcinoma represents approximately 10% of cases of the malignant ovarian epithelial tumors.
According to literature, the vitamin A (carotenoids and retinoids) plays an essential role in cell proliferation, differentiation
and apoptosis in both normal and neoplastic ovarian tissues. Apart from that, the retinoids alter a cytotoxic effect of chemio-
therapeutics, i.e. docetaxel, on ovarian cancer cell lines. Retinoids act on cancer cells throughout different mechanism than
taxanes, so they may be the potential candidates for the new treatment strategies of ovarian cancer.The aim of the study was
to determine the effects of vitamin A family compounds (retinol, β-carotene, lycopene, all-trans -, 9-cis – and 13-cis retinoic
acid) on the growth and proliferation of CRL-11731 endometrioid ovary cancer cell line and on docetaxel and estradiol
activity in this culture. The assay was based on [3H] thymidine incorporation and the proliferative activity of PCNA- and
Ki 67-positive cells. The apoptotic index and expression of the Bcl-2 and p53 antigens in CRL-11731 cells were also stud-
ied. Among vitamin A family compounds retinol and carotenoids, but not retinoids, inhibited the growth of cancer cells in
dose dependent manner. Only the concentration of 100 μM of docetaxel inhibited incorporation [3H] thymidine into CRL-
11731 cancer cells. Retinol (33.4%±8.5), carotenoids (β-carotene 20 μM 4.7%±2.9, 50 μM 2.2%±0.9; lycopene 10 μM
7.6%±0.8, 20 μM 5.2%±2.5, 50 μM 2.9%±1.2), and 13-cis retinoic acid (19.7%±2.2) combined with docetaxel (100 μM)
significantly decreased the percentage of proliferating cells (p<0.0001). The antiproliferative action of lycopene alone and
in combination with docetaxel was also confirmed in immunohistochemical examination (decreased the percentage of
PCNA and Ki67 positive cells). Also retinol (10 μM) and lycopene (20 and 50 μM) combined with estradiol (0.01 μM) sta-
tistically decreased the percentage of proliferating cells compared to the control (p<0.0001) and estradiol (p<0.01,
p<0.0001) group (63.5%±14.8, 61.0%±20.6, 15.0%±5.5 respectively). In our experiments, the compounds tested induced an
apoptotic effect. Docetaxel and estradiol increased the percentage of apoptotic cells (71% apoptotic cells after administra-
tion of 10 μM all-trans retinoic acid combined with 0.01 μM estradiol, p<0.0001). β-carotene, lycopene and all-trans
retinoic acid alone and in combination with docetaxel were found to influence the expression of bcl-2 and p53 antigen in
the cells examined.The results of our study justified an important role of vitamin A in the pathophysiology of the ovarian
endometrioid cancer.
Key words: vitamin A, docetaxel, estradiol, CRL-11731, proliferation, apoptosis
Correspondence: E. Czeczuga-Semeniuk, Dept. of Reproduction
and Gynecological Endocrinology, Medical University of Bia³ystok,
15-276 Bia³ystok, M. Sk³odowskiej-Curie 24A, Poland; 
tel.: (+4885) 7468343, fax.: (+4885) 7468818, 
e-mail: czeczuga@wp.pl
histological type originates from foci of endometriosis
and endometrial cysts localized in the ovary [3]. The
structural-histological similarity between endometri-
oid ovarian cancer and endometrioid uterine carcino-
ma suggests its development from malignant transfor-
mation of surface epithelium [4]. Wang et al. have
proved that ovarian carcinoma is a heterogeneous
pathology, in which histological phenotype correlates
with certain phenomena on the molecular level [5],
and that certain genetic changes may cause malignant
transformation of endometriosis [6]. Although ovarian
carcinoma responds to chemotherapy (paclitaxel, car-
boplatin) [7], its prognosis still remain poor due to
recurrent nature. Therefore, a search is conducted for
compounds/drugs showing other mechanisms, among
which vitamin A derivatives play a major role [8].
Vitamin A (carotenoids and retinoids) is believed to
have a fundamental role in proliferation, differentia-
tion and apoptosis of ovarian cancer cells [9,10]. Since
its active metabolites, mainly retinoic acid, by binding
to specific nuclear receptors (RAR and RXR) activate
transcription processes, retinoids seem to play chemo-
preventive and chemotherapeutic roles in ovarian car-
cinoma [11].
As revealed by epidemiological studies, also
carotenoids, i.e. retinoid precursors, provided to the
human body with plant and animal foods reduce the
risk of ovarian cancer [12]. It has been shown that
patients with advanced forms of carcinoma have lower
serum carotenoid concentrations [13,14]. 
β-carotene, the most widely spread carotenoid
belonging to the provitamin A group (split into two
vitamin A molecules), acts as an antioxidant in the
human body and can reach its target cells via blood in
an unchanged form [15]. Among carotenoids that do
not belong to the provitamin A group, lycopene is the
most active antioxidant [16].
The study objective was to assess the effect of com-
pounds belonging to the vitamin A family (retinol, β-
carotene, lycopene, trans retinoic acid, 9-cis retinoic
acid and 13-cis retinoic acid) on the growth and prolif-
eration of the human ovarian endometrioid cancer cell
line CRL-11731, and to evaluate the influence of the
compounds tested on the activity of docetaxel and
estradiol in the culture of cancer cells.  We also made
an attempt to elucidate the effect of the substances
tested on the stimulation of the apoptotic pathway in
ovarian endometrioid carcinoma. 
Materials and methods 
Chemicals. Retinol (all-trans retinol, Sigma) β−carotene (β-
carotene, Sigma), lycopene (Lycopene, Sigma), 9-cis retinoic acid
(9-cis Retinoic acid, Sigma), 13-cis retinoic acid (Isotretinoin), all-
trans retinoic acid (Tretinoin), tamoxifen (Citrate Salt Tamoxifen),
17 β-estradiol (1,3,5 [10]-estratriene-3, 17 β-diol) and docetaxel
(Taxotere, ≥ 97% [HPLC]) were obtained from Sigma (St. Louis,
MO, USA). The following antibodies: PCNA – Proliferating Cell
Nuclear Antigen: monoclonal mouse antibody (clone PC 10), Ki
67: monoclonal mouse antibody (clone Ki 67), Bcl-2 oncoprotein:
monoclonal mouse antibody (clone 12) and p53 protein: mono-
clonal mouse antibody (clone DO-7) was obtained from Dako
(Glostrup, Denmark).
Retinol, carotenoids and retinoids were diluted in ethyl alcohol
(lycopene in THF) and then in the culture medium, to final con-
centrations of 0.001 – 10 μM. Tamoxifen and 17 β-estradiol were
added to the culture at a concentration of 10 and 0.001 μM, respec-
tively. Docetaxel was diluted in the culture medium to final con-
centrations of 0.00001, 0.0001, 0.001, 0.01, 0.1, 0.2, 0.5, 1.0 and
10.0 μM.
Culture of cell line MCF-7. The study was carried out on the cell
line CRL-11731 of human ovary cancer (American Type Culture
Collection, Rockville, MD). Cells were maintained in 75 cm2 tis-
sue culture flask (Sarsted, USA), under standard culture condi-
tions; at 37°C, 5% CO2 /95% air humidified incubator in 1:1mix-
ture of MCDB 105 medium and 199 medium (Sigma-Aldrich,
Poland), were renewal every 3-4 days. Culture media contained
15% of fetal bovine serum (Sigma-Aldrich, Poland), and enriched
with 50 U/ml antibiotic, antimycotic solution (penicillin, strepto-
mycin, amphotericin B (Sigma-Aldrich, Poland). When cells
reached 80% confluence cells were rinse with 0.05%
trypsin/0.02% EDTA solution (Sigma-Aldrich, Poland) to remove
all traces of serum. After that culture were incubated witch 3 ml of
trypsin -EDTA solution. Cells layer were observed under an invert-
ed microscope and cells dispersed usually within 5 to 15 minutes
of incubation. Cells were aspirate by pipeting with complete
growth medium (6 to 8 ml). Appropriate medium were added for
cell suspension in new culture vessels. Subcultivation ratio was
1:3. For experiment cells were collected and seeded in 6 well cul-
ture plates (Sarsted, USA). The cells were incubated for 24 h prior
to treatment and allowed to proliferate to 70% – 80% confluence
before commencement of each experiment, without serum in
MCDB105/199 medium. 
The methods for [3H] thymidine incorporation, immunocyto-
chemical examinations and determination of apoptotic index were
described previously in Folia Histochem Cytobiol. 2004;42:221-
227 and Acta Biochim Polon. 2004;51:733-745.
Statistical analysis. In all the experiments, mean values ± standard
deviation (SD) for 4 measurements of each parameter were calcu-
lated. The Mann-Whitney test was used to perform statistical
analysis.
Results
The effects of retinol, carotenoids and retinoids
as well as docetaxel and estradiol on [3H]
thymidine incorporation into carcinoma cells.
Of the compounds of the vitamin A family, retinol and
carotenoids were found to inhibit incorporation of
labeled thymidine into cancer cells in a dose-depend-
ent manner. Addition of 50 μM retinol to the cell cul-
ture nearly totally inhibited proliferation of the cells
tested (Fig. 1).
Retinoids showed no such effects in a 24h culture
(Fig. 2). 
The concentrations of 0.0000001 to 1 μM docetax-
el stimulated the proliferation of the cell line CRL-
11731. We observed the inhibition of [3H] thymidine
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incorporation into cancer cells only after adding 
100 μM docetaxel to the cell culture (36%) (Fig. 3).
We used the same concentration of this chemothera-
peutic in further study phases.
Estradiol used at a concentration of 0.01 μM slight-
ly inhibited the proliferation of ovarian carcinoma
cells (83%) (Fig. 4). 
The effects of retinol, carotenoids and retinoids
combined with docetaxel or estradiol on [3H]
thymidine incorporation into carcinoma cells.
Retinol and carotenoids added to cell culture simulta-
neously with docetaxel (100 μM) statistically signifi-
cantly reduced the percentage of proliferating cells as
compared to the control and docetaxel group. Also
retinol (10 μM) and lycopene (20 and 50 μM) added to
the culture simultaneously with estradiol (0.01 μM) had
a similar effect. On the other hand, irrespective of the
concentrations, β-carotene stimulated the growth of
cancer cells in the presence of estradiol (Fig. 5).
Among retinoids, only 10 μM 13-cis retinoic acid
statistically significantly inhibited the proliferation of
cancer cells. Retinoids added to the culture in combi-
nation with estradiol stimulated the growth of the cell
line tested (Fig. 6).
Immunohistochemical examinations
The antiproliferative actions of lycopene alone and in
combination with docetaxel were also confirmed in
immunohistochemical examinations (decreased per-
centage of PCNA and Ki67 positive ovarian cancer
cells) (Table 1).
In immunohistochemical examinations, β-carotene
alone and combined with docetaxel decreased the per-
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Fig. 1. Influence of retinol and carotenoids on [3H]-thymidine incor-
poration into CRL-11731 ovary cancer cells. Control = 100%. Expo-
sure time 24 h. Data presented as mean values ± SD (n=4).
Fig. 2. Influence of retinoids on [3H]-thymidine incorporation into
CRL-11731 ovary cancer cells. Control = 100%. Exposure time 24
h. Data presented as mean values ± SD (n=4).
Fig. 4. Influence of estradiol on [3H]-thymidine incorporation into
CRL-11731 ovary cancer cells. Control = 100%. Exposure time 24
h. Data presented as mean values ± SD (n=4).
Fig. 3. Influence of docetaxel on [3H]-thymidine incorporation
into CRL-11731 ovary cancer cells. Control = 100%. Exposure
time 24 h. Data presented as mean values ± SD (n=4).
centage of bcl-2 positive and increased the percentage
of p53 positive ovarian cancer cells. The same effect
was also observed for all concentrations of lycopene
alone and combined with docetaxel (Tab. 1). Among
retinoids, only all-trans retinoic acid (0.01 and 10 μM)
influenced the percentages of bcl-2 and p53 positive
ovarian cancer cells (Table 2).
Assessment of the apoptotic index
All the compounds tested alone and in combination
with docetaxel or estradiol stimulated the apoptotic
pathway (Table 3 and 4). The percentage of apoptotic
cells increased after addition of docetaxel, in some
cases also when estradiol was added.  We observed the
greatest percentage of apoptotic cells (71%) after addi-
tion of 10 μM all-trans retinoic acid combined with
0.01 μM estradiol.
Discussion
The vitamin A family compounds take part in many
physiological and pathological processes in the ovary
[9,10].
The presence of carotenoid pigments in physiolog-
ical and pathological ovarian tissues has been previ-
ously demonstrated by our team [17,18]. Furthermore,
among the ovarian epithelial neoplasms, the endometri-
oid carcinoma tissue has the highest total carotenoid
content (β-carotene, β-cryptoxanthin, lutein, zeaxan-
thin, canthaxanthin, epoxy-lutein, neoxanthin, violax-
anthin and mutatoxanthin) and the highest percentage
of the provitamin A group carotenoids (e.g. β-carotene)
[17]. Thus, it is likely that carotenoids may have an
influence on proliferation, differentiation and apoptosis
of the ovarian carcinoma cells. In addition, a coordinate
inactivation of a group of 3p genes by genetic or epige-
netic mechanism for example under-expressed putative
tumor suppressor genes, i.e. retinoic acid receptor 
β (RAR β) may be an important factor for the patho-
genesis of ovarian cancer [11]. It has also been demon-
strated that β-carotene can reach target tissues in an
unchanged form and undergo metabolic transforma-
tion into retinoids directly in the ovary [15].
The results of Wu et al. have shown various ways in
which retinoids affect ovarian carcinoma cells.
Retinoids were found to inhibit the growth of the cell
line CA-OV3 but not SK-OV3. The mechanism was
associated with blocking of the cell cycle in the G-0
and/or G-1 phase [19]. In a 48-hour experiment, 10 μM
retinoic acid and 9-cis retinoic acid did not restrain the
incorporation of a labeled thymidine into the cancer
cells of six epithelial cell lines, whereas in the cell line
OV 266 they had a stimulating effect. Both retinoic acid
and 9-cis retinoic acid inhibited cell proliferation in
approximately 80% only in the OV 167 and OV 177 cell
lines [20]. The cancer cells used in our experiments
originated from an aggressive ovarian endometrioid
tumor (stage 3 grade 3) and were highly proliferative
ones. We observed a similar effect of retinoids (10 μM)
in a 24-hour culture of the cell line CRL-11731.
The cancer cell growth inhibition was well-defined
after application of 10 μM retinol and 20 and 50 μM 
β-carotene and lycopene. Retinol and lycopene coun-
teracted the stimulatory action of estradiol and 
β-carotene (irrespectively of concentrations), whereas
retinoids enhanced this action. According to literature,
β-carotene and lycopene are the most abundant
carotenoids in the human tissues [21,22]. However, we
did not confirm the presence of lycopene in the studied
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Fig. 5. Influence of retinol and carotenoids in combination with
docetaxel and estradiol on [3H]-thymidine incorporation into
CRL-11731 ovary cancer cells. Control = 100%. Exposure time
24 h. Data presented as mean values ± SD (n=4). Cocentrations:
docetaxel 100 μM, estradiol 0.01 μM. * – p<0.0001 relative to
the control group, ? – p<0.0001 relative to the docetaxel group,
? – p<0.001 relative to the estradiol group, ?? – p<0.0001 rel-
ative to the estradiol group.
Fig. 6. Influence of retinoids in combination with docetaxel and
estradiol on [3H]-thymidine incorporation into CRL-11731 ovary
cancer cells. Control = 100%. Exposure time 24 h. Data present-
ed as mean values ± SD (n=4). Cocentrations: docetaxel 100 μM,
estradiol 0.01 μM. * – p<0.0001 relative to the control group, ?
– p<0.0001 relative to the docetaxel group.
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Table 1. Percentage of PCNA, Ki67, Bcl-2 and p53 positive CRL-11731 ovary cancer cells. 
100 µM docetaxel, 0.01 µM estradiol; exposure time 24 h.
Data presented as mean values ± S.D. (n=4);
Statistically significant differences:
Relative to the control group:
* p<0.02
** p<0.004
*** p<0.001
**** p<0.0005
***** p<0.0004
****** p<0.0001
Relative to the docetaxel group:
? p<0.02
?? p<0.001
??? p<0.0005
???? p<0.0004
????? p<0.00001
Relative to the estradiol group:
? p<0.0001
Immunostaining of  PCNA, Ki67, Bcl-2 and p53 of  ovary cancer cells:
+ weak
++ mild
+++ strong
ovarian tissues [17]. This may result from the fact that
lycopene acts as an intermediate link in the formation
of carotenoids, such as β-carotene, or its role as a free
radical scavenger [23].
In our study, only lycopene, apart from promoting
apoptosis, affected the expression of PCNA and Ki67
antigens in the cancer cell line CRL-11731.
Retinoids have been shown to increase a cytotoxic
effect of the chemioterapeutics, also docetaxel, in the
cell lines of ovarian carcinoma [24]. Docetaxel is 
a semisynthetic anticancer agent which shows its
action throughout binding to β-tubulins and stabilizing
the microtubular network, thus blocking the cell cycle
at G2-M phase and subsequent regulate the apoptosis
of the cells [25,26], also in ovarian cancer cells [27]. 
The IC50 concentrations for docetaxel were 0.8 nM
for CRL-11731 cells in 72 h experiments [28]. Our
findings revealed that low doses of docetaxel
(0.0000001 – 0.00001 μM) strongly stimulated the
growth of ovarian cancer cells (24 h experiments).  
Retinol, β-carotene, lycopene and 13-cis retinoic
acid added to the cell culture simultaneously with doc-
etaxel (100 μM) significantly reduced the percentage
of proliferating cells and increased the percentage of
apoptotic cells. As shown by in vitro studies, the inhi-
bition of the growth of ovarian cancer cells could
occur via a number of mechanisms, including apopto-
sis induction [20,29,30]. 
Programmed cell death, i.e. apoptosis, is a funda-
mental process of tissue development and homeostasis,
stimulated by growth factors withdrawal, deregulation
of the cell cycle, DNA damage or lack of the receptor-
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Table 2. Percentage of PCNA, Ki67, Bcl-2 and p53 positive CRL-11731 ovary cancer cells.
100 µM docetaxel, 0.01 µM estradiol; exposure time 24 h.
Data presented as mean values ± S.D. (n=4);
Statistically significant differences:
Relative to the control group:
* p<0.001
** p<0.0005
*** p<0.0001
Relative to the docetaxel group:
? p<0.001
?? p<0.0005
??? p<0.0001
Relative to the estradiol group:
? p<0.0005
?? p<0.0001
Immunostaining of  PCNA, Ki67, Bcl-2 and p53 of  ovary cancer cells:
+ weak
++ mild
+++ strong
ligand interaction [31,32,33]. Apoptosis may be
induced in order to remove abnormal cells. The mech-
anism of apoptosis involves morphological and bio-
chemical processes. Apoptosis is the highly regulated
process involving the sequential activation of multiple
proteins (caspases and proteases). Lack of proper
apoptotic regulation can result in various diseases and
may cause tumorgenesis of ovarian cells [34]. The ini-
tial development of ovarian carcinoma is associated
with a high expression of Bcl-2 proteins and in some
cases with a defect in p53 gene or its regulation. So
these cells are resistant to DNA damage- induced
apoptosis and cell cycle control. Programmed cell
death in ovarian cancer can be related to cell cycle
control [35] and a "cross-talk" with AP1 [36] and EGF
[37].
Bcl-2 is one of the factors which strongly inhibits
apoptosis. We observed an enhanced apoptotic effect
of 20 μM 9-cis retinoic acid combined with docetaxel
and estradiol. Also 10 μM of all-trans retinoic acid
combined with estradiol increased the percentage of
apoptotic cells. Nahme et al. concluded that ATRA
synergistically enhanced docetaxel toxicity by down
regulation of Bcl-2 expression [38]. Our results
showed that apart from β-carotene and lycopene, only
concentrations of all-trans retinoic acid used in the
study decreased the percentage of bcl-2 positive cells
and increased the percentage of p53 positive cells. 
Also p53 has been reported to down regulate the
antiapoptotic Bcl-2 protein [39]. It has been proposed
that the low levels of p53 determine growth arrest and
high levels determine apoptosis [40]. Thus, high levels
of p53 are required for the transactivation of proapop-
totic genes. 
The process of apoptosis can also be initiated with-
out Bcl-2 proteins [41].
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Table 3. Influence of retinol β-carotene and lycopene alone and combined with docetaxel and estradiol on apoptosis in CRL-11731 ovary
carcinoma cells.
100% = viable (%) + apoptotic (%) + apoptopic/necrotic (%) + necrotic (%) cells. 100 μM docetaxel, 0.01 μM estradiol.
Exposure time 24 h. Data presented as mean values ±S.D. (n=4); Statistically significant differences:
* p<0.001 relative to the control group
** p<0.0001
? p<0.01 relative to the docetaxel group
?? p<0.0001
? p<0.002 relative to the estradiol group
? p<0.01 relative to the retinol 10 μM group
?? p<0.0003
? p<0.01 relative to the β-carotene 20 μM group
? p<0.01 relative to the lycopene 50 μM group
The p53 pathway as well as estrogen signaling
plays an important role for differentiation and growth
of CRL-11731 cells [42]. 
The carcinogenesis in the ovary is affected by exo-
and endogenous estrogens that act via estrogen recep-
tors α and β (ERα and ERβ) [43]. Loss of ERβ expres-
sion is a key step in a malignant transformation
process.  ERβ upregulates apoptosis in ovarian cancer
cells [44] and mediates estrogen-induced apoptosis
[45]. In our study, among examined compounds, only
retinol and lycopene overcame a proliferative action of
estradiol in culture of ovary cancer cell line CRL-
11731. A simultaneous application of lycopene and
estradiol resulted in a presence of a highest percentage
of apoptotic cells in the culture. The vitamin A family
compounds role and the molecular events responsible
for induction of apoptosis in CRL-11731 ovary cancer
cells need some further investigations.
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